Structures by: Khan H.
Total: 10
C18H20ClN3O
C18H20ClN3O
Dalton transactions (Cambridge, England : 2003) (2011) 40, 36 9202-9211
a=10.0536(15)Å b=14.736(2)Å c=12.5743(19)Å
α=90.00° β=113.060(2)° γ=90.00°
C34H34Cl2CuN6O2
C34H34Cl2CuN6O2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 36 9202-9211
a=19.020(8)Å b=14.289(6)Å c=18.525(8)Å
α=90.00° β=96.193(6)° γ=90.00°
C36H38Cl2CuN6O2
C36H38Cl2CuN6O2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 36 9202-9211
a=40.2231(18)Å b=40.2231(18)Å c=11.5607(11)Å
α=90.00° β=90.00° γ=120.00°
C17H18ClN3O
C17H18ClN3O
Dalton transactions (Cambridge, England : 2003) (2011) 40, 36 9202-9211
a=13.5978(19)Å b=11.6143(16)Å c=20.150(3)Å
α=90.00° β=98.910(2)° γ=90.00°
Ciprofloxacin diflunisal salt
C30H26F3N3O6
CrystEngComm (2014) 16, 32 7393
a=7.116(2)Å b=9.994(4)Å c=19.147(7)Å
α=81.470(9)° β=82.505(8)° γ=87.191(8)°
Ciprofloxacin indoprofen hydrate salt
C34H35FN4O7
CrystEngComm (2014) 16, 32 7393
a=10.325(4)Å b=12.615(5)Å c=12.916(5)Å
α=71.510(7)° β=74.334(7)° γ=70.672(7)°
Ciprofloxacin diflunisal salt
C30H26F3N3O6
CrystEngComm (2014) 16, 32 7393
a=7.116(2)Å b=9.994(4)Å c=19.147(7)Å
α=81.470(9)° β=82.505(8)° γ=87.191(8)°
Ciprofloxacin indoprofen hydrate salt
C34H35FN4O7
CrystEngComm (2014) 16, 32 7393
a=10.325(4)Å b=12.615(5)Å c=12.916(5)Å
α=71.510(7)° β=74.334(7)° γ=70.672(7)°
1-Methyl-1H-benzimidazole-2(3H)-thione
C8H8N2S
Acta Crystallographica Section E (2008) 64, 6 o1141
a=9.997(4)Å b=5.8140(7)Å c=13.703(4)Å
α=90.00° β=94.05(3)° γ=90.00°
[(Methylcarbamothioyl)disulfanyl]methyl <i>N</i>-methylcarbamodithioate
C5H10S5N2
Acta Crystallographica Section E (2010) 66, 10 o2671
a=7.1880(10)Å b=7.884(2)Å c=10.219(2)Å
α=101.23(3)° β=96.85(3)° γ=102.74(3)°